(Q33476908)

27 July 2017

title

High-dose methotrexate in small cell lung cancer. Lack of efficacy in preventing CNS relapse (English)

1 reference

27 July 2017

High-dose methotrexate in small cell lung cancer: Lack of efficacy in preventing CNS relapse (English)

1 reference

10.1002/1097-0142(19830315)51:6<1056::AID-CNCR2820510614>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1056::AID-CNCR2820510614%3E3.0.CO;2-V

19 September 2023

1 reference

1 reference

10.1002/1097-0142(19830315)51:6<1056::AID-CNCR2820510614>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1056::AID-CNCR2820510614%3E3.0.CO;2-V

19 September 2023

author name string

E. S. Neijstrom

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6295620

19 September 2023

R. L. Capizzi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6295620

19 September 2023

S. A. Rudnick

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6295620

19 September 2023

M. Kirsch

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6295620

19 September 2023

D. Delaney

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6295620

19 September 2023

L. Kahn

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6295620

19 September 2023

S. Lipper

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6295620

19 September 2023

C. Carney

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6295620

19 September 2023

language of work or name

English

0 references

publication date

1 March 1983

1 reference

27 July 2017

15 March 1983

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6295620

full work available at URL

19 September 2023

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%2819830315%2951%3A6%3C1056%3A%3AAID-CNCR2820510614%3E3.0.CO%3B2-V

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6295620

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19830315)51:6%3C1056::AID-CNCR2820510614%3E3.0.CO;2-V

19 September 2023

1 reference

10.1002/1097-0142(19830315)51:6<1056::AID-CNCR2820510614>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1056::AID-CNCR2820510614%3E3.0.CO;2-V

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19830315)51:6%3C1056::AID-CNCR2820510614%3E3.0.CO;2-V

19 September 2023

1 reference

10.1002/1097-0142(19830315)51:6<1056::AID-CNCR2820510614>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1056::AID-CNCR2820510614%3E3.0.CO;2-V

19 September 2023

1 reference

27 July 2017

volume

51

1 reference

27 July 2017

issue

6

1 reference

27 July 2017

page(s)

1056-1061

1 reference

Small-Cell Carcinoma of the Lung: Therapeutic Management

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819830315%2951%3A6%3C1056%3A%3AAID-CNCR2820510614%3E3.0.CO%3B2-V

Chemotherapy of advanced small-cell anaplastic carcinoma. Superiority of a four-drug combination to a three-drug combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819830315%2951%3A6%3C1056%3A%3AAID-CNCR2820510614%3E3.0.CO%3B2-V

Small-cell carcinoma of the lung: combined chemotherapy and radiation: a Southwest Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819830315%2951%3A6%3C1056%3A%3AAID-CNCR2820510614%3E3.0.CO%3B2-V

The value of adriamycin in overcoming resistance to methotrexate in tissue culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819830315%2951%3A6%3C1056%3A%3AAID-CNCR2820510614%3E3.0.CO%3B2-V

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819830315%2951%3A6%3C1056%3A%3AAID-CNCR2820510614%3E3.0.CO%3B2-V

Cancer chemotherapy reports

21 January 2018

3

4

2

Matthews

1973

1 reference

10.1002/1097-0142(19830315)51:6<1056::AID-CNCR2820510614>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1056::AID-CNCR2820510614%3E3.0.CO;2-V

Early detection of bone-marrow invasion in oat-cell carcinoma of the lung

19 September 2023

4

1 reference

10.1002/1097-0142(19830315)51:6<1056::AID-CNCR2820510614>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1056::AID-CNCR2820510614%3E3.0.CO;2-V

Proceedings: Small cell carcinoma of the lung: staging, paraneoplastic syndromes, treatment, and survival

19 September 2023

6

1 reference

10.1002/1097-0142(19830315)51:6<1056::AID-CNCR2820510614>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1056::AID-CNCR2820510614%3E3.0.CO;2-V

Alkylating agents in bronchogenic carcinoma

19 September 2023

9

1 reference

10.1002/1097-0142(19830315)51:6<1056::AID-CNCR2820510614>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1056::AID-CNCR2820510614%3E3.0.CO;2-V

Lung cancer: clinical trial of radiotherapy alone vs. radiotherapy plus cyclophosphamide

19 September 2023

10

1 reference

10.1002/1097-0142(19830315)51:6<1056::AID-CNCR2820510614>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1056::AID-CNCR2820510614%3E3.0.CO;2-V

19 September 2023

11

7

925

Edmondson

1976

1 reference

10.1002/1097-0142(19830315)51:6<1056::AID-CNCR2820510614>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1056::AID-CNCR2820510614%3E3.0.CO;2-V

Evaluation of methotrexate in the treatment of bronchogenic carcinoma

19 September 2023

12

1 reference

10.1002/1097-0142(19830315)51:6<1056::AID-CNCR2820510614>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1056::AID-CNCR2820510614%3E3.0.CO;2-V

19 September 2023

13

60

239

Dombernowsky

1976

1 reference

10.1002/1097-0142(19830315)51:6<1056::AID-CNCR2820510614>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1056::AID-CNCR2820510614%3E3.0.CO;2-V

19 September 2023

15

62

473

Covalli

1978

1 reference

10.1002/1097-0142(19830315)51:6<1056::AID-CNCR2820510614>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1056::AID-CNCR2820510614%3E3.0.CO;2-V

19 September 2023

16

61

93

Eagan

1977

1 reference

10.1002/1097-0142(19830315)51:6<1056::AID-CNCR2820510614>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1056::AID-CNCR2820510614%3E3.0.CO;2-V

Cancer chemotherapy reports

19 September 2023

17

6

399

Wasserman

1975

1 reference

10.1002/1097-0142(19830315)51:6<1056::AID-CNCR2820510614>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1056::AID-CNCR2820510614%3E3.0.CO;2-V

Oat cell carcinoma of the lung.Combination treatment with radiotherapy and cyclophosphamide, adriamycin, vincristine, and methotrexate

19 September 2023

18

1 reference

10.1002/1097-0142(19830315)51:6<1056::AID-CNCR2820510614>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1056::AID-CNCR2820510614%3E3.0.CO;2-V

“Total” Therapy for Small Cell Carcinoma of the Lung

19 September 2023

19

1 reference

10.1002/1097-0142(19830315)51:6<1056::AID-CNCR2820510614>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1056::AID-CNCR2820510614%3E3.0.CO;2-V

19 September 2023

20

63

163

Cohen

1979

1 reference

10.1002/1097-0142(19830315)51:6<1056::AID-CNCR2820510614>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1056::AID-CNCR2820510614%3E3.0.CO;2-V

19 September 2023

21

61

349

Cohen

1977

1 reference

10.1002/1097-0142(19830315)51:6<1056::AID-CNCR2820510614>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1056::AID-CNCR2820510614%3E3.0.CO;2-V

Management of small cell carcinoma of the lung.Therapy, staging, and biochemical markers

19 September 2023

23

1 reference

10.1002/1097-0142(19830315)51:6<1056::AID-CNCR2820510614>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1056::AID-CNCR2820510614%3E3.0.CO;2-V

Combination chemotherapy of advanced lung cancer.A randomized trial

19 September 2023

24

1 reference

10.1002/1097-0142(19830315)51:6<1056::AID-CNCR2820510614>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1056::AID-CNCR2820510614%3E3.0.CO;2-V

Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections

19 September 2023

25

1 reference

10.1002/1097-0142(19830315)51:6<1056::AID-CNCR2820510614>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1056::AID-CNCR2820510614%3E3.0.CO;2-V

19 September 2023

32

61

1

Alexander

1977

1 reference

10.1002/1097-0142(19830315)51:6<1056::AID-CNCR2820510614>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1056::AID-CNCR2820510614%3E3.0.CO;2-V

Combination chemotherapy for small cell carcinoma of the lung

19 September 2023

33

1 reference

10.1002/1097-0142(19830315)51:6<1056::AID-CNCR2820510614>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1056::AID-CNCR2820510614%3E3.0.CO;2-V

19 September 2023

34

63

519

Abeloff

1979

1 reference

10.1002/1097-0142(19830315)51:6<1056::AID-CNCR2820510614>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1056::AID-CNCR2820510614%3E3.0.CO;2-V

Phase I study of high doses of methotrexate with citrovorum factor in patients with lung cancer

19 September 2023

35

1 reference

10.1002/1097-0142(19830315)51:6<1056::AID-CNCR2820510614>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1056::AID-CNCR2820510614%3E3.0.CO;2-V

19 September 2023

36

62

397

Jacobs

1978

1 reference

10.1002/1097-0142(19830315)51:6<1056::AID-CNCR2820510614>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1056::AID-CNCR2820510614%3E3.0.CO;2-V

Use of Plasma Pharmacokinetics to Predict and Prevent Methotrexate Toxicity

19 September 2023

37

1 reference

10.1002/1097-0142(19830315)51:6<1056::AID-CNCR2820510614>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1056::AID-CNCR2820510614%3E3.0.CO;2-V

CNS metastases in small cell bronchogenic carcinoma.Increasing frequency and changing pattern with lengthening survival

19 September 2023

38

1 reference

10.1002/1097-0142(19830315)51:6<1056::AID-CNCR2820510614>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1056::AID-CNCR2820510614%3E3.0.CO;2-V

Chemoimmunotherapy of small cell bronchogenic carcinoma

19 September 2023

39

1 reference

10.1002/1097-0142(19830315)51:6<1056::AID-CNCR2820510614>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1056::AID-CNCR2820510614%3E3.0.CO;2-V

Small-cell carcinoma of the lung: attempt to remedy causes of past therapeutic failure

19 September 2023

40

1 reference

10.1002/1097-0142(19830315)51:6<1056::AID-CNCR2820510614>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1056::AID-CNCR2820510614%3E3.0.CO;2-V

A randomized combined modality trial in small cell carcinoma of the lung comparison of combination chemotherapy-radiation therapy versus cyclophosphamide-radiation therapy effects of maintenance chemotherapy and prophylactic whole brain irradiation

19 September 2023

41

1 reference

10.1002/1097-0142(19830315)51:6<1056::AID-CNCR2820510614>3.0.CO;2-V

https://api.crossref.org/works/10.1002/1097-0142(19830315)51:6%3C1056::AID-CNCR2820510614%3E3.0.CO;2-V

19 September 2023

Identifiers

10.1002/1097-0142(19830315)51:6<1056::AID-CNCR2820510614>3.0.CO;2-V

1 reference

27 July 2017

1 reference